New antibiotic structures from fermentations

Bibliography

• National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004;32:470-85
   PubMed Web of Science ®Google Scholar
• Talbot GH, Bradley J, Edwards JE Jr, Bad bugs need drugs: an update on the development pipeline from the antimicrobial availability task force of the Infectious Diseases Society of America. Clin Infect Dis 2006;42:657-68
   PubMed Web of Science ®Google Scholar
• Spellberg B, Guidos R, Gilbert D, The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clin Infect Dis 2008;46:155-64
   PubMed Web of Science ®Google Scholar
• Klevens RM, Morrison MA, Nadle J, Invasive methicillin-resistant Staphylococcus aureus infections in the United States. J Am Med Assoc 2007;298:1763-71
   PubMed Web of Science ®Google Scholar
• Singh SB, Barrett JF. Empirical antibacterial drug discovery-foundation in natural products. Biochem Pharmacol 2006;71:1006-15
   PubMed Web of Science ®Google Scholar
• Payne DJ, Gwynn MN, Holmes DJ, Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat Rev Drug Discov 2007;6:29-40
   PubMed Web of Science ®Google Scholar
• Merck & Co., Inc. Antibiotic compound. WO2005009391A2; 2005
   Google Scholar
• Wang J, Soisson SM, Young K, Platensimycin is a selective FabF inhibitor with potent antibiotic properties. Nature 2006;441:358-61
   PubMed Web of Science ®Google Scholar
• Merck & Co., Inc. Antibiotic compound. WO2005115400A2; 2005
   Google Scholar
• Wang J, Kodali S, Lee SH, Platencin is a dual fabf and fabh inhibitor with potent in vivo antibiotic properties. Proc Natl Acad Sci USA 2007;104:7612-16
   PubMed Web of Science ®Google Scholar
• Singh SB, Jayasuriya H, Ondeyka JG, Isolation, structure, and absolute stereochemistry of platensimycin, a broad spectrum antibiotic discovered using an antisense differential sensitivity strategy. J Am Chem Soc 2006;128:11916-20, 15547
   PubMed Web of Science ®Google Scholar
• Jayasuriya H, Herath KB, Zhang C, Isolation and structure of platencin: a novel FabH and FabF dual inhibitor with potent broad spectrum antibiotic activity produced by Streptomyces platensis MA7339. Angew Chem Int Ed 2007;46:4684-8
   PubMed Web of Science ®Google Scholar
• Herath KB, Attygalle AB, Singh SB. Biosynthetic studies of platensimycin. J Am Chem Soc 2007;129:15422-3
   PubMed Web of Science ®Google Scholar
• Herath K, Attygalle AB, Singh SB. Biosynthetic studies of platencin. Tetrahedron Lett 2008;49:5755-8
   Google Scholar
• Merck & Co., Inc. Antibiotic compound. WO2006086012A2; 2006
   Google Scholar
• Jayasuriya H, Herath K, Ondeyka JG, Isolation and structure elucidation of thiazomycin – a potent thiazolyl peptide antibiotic from Amycolatopsis fastidiosa. J Antibiot (Tokyo) 2007;60:554-64
   PubMed Web of Science ®Google Scholar
• Singh SB, Occi J, Jayasuriya H, Antibacterial evaluations of thiazomycin – a potent thiazolyl peptide antibiotic from Amycolatopsis fastidiosa. J Antibiot (Tokyo) 2007;60:565-71
   PubMed Web of Science ®Google Scholar
• Zhang C, Zink DL, Ushio M, Isolation, structure, and antibacterial activity of thiazomycin A, a potent thiazolyl peptide antibiotic from Amycolatopsis fastidiosa. Bioorg Med Chem 2008;16:8818-23
   PubMed Web of Science ®Google Scholar
• Zhang C, Herath K, Jayasuriya H, Thiazomycins, thiazolyl peptide antibiotics from Amycolatopsis fastidiosa. J Nat Prod 2009;72:841-7
   Google Scholar
• Constantine KL, Mueller L, Huang S, Conformation and absolute configuration of nocathiacin I determined by NMR spectroscopy and chiral capillary electrophoresis. J Am Chem Soc 2002;124:7284-5
   PubMed Web of Science ®Google Scholar
• Li W, Leet JE, Ax HA, Nocathiacins, new thiazolyl peptide antibiotics from Nocardia sp. I. Taxonomy, fermentation and biological activities. J Antibiot (Tokyo) 2003;56:226-31
   PubMed Web of Science ®Google Scholar
• Merck & Co., Inc. Antibiotic compound. WO2008024285A2; 2008
   Google Scholar
• Zhang C, Occi J, Masurekar P, Isolation, structure, and antibacterial activity of philipimycin, a thiazolyl peptide discovered from Actinoplanes philippinensis MA7347. J Am Chem Soc 2008;130:12102-10
   PubMed Web of Science ®Google Scholar
• Recombinogen Ltd. Cyclic lipopeptide. WO2007072082A1; 2007
   Google Scholar
• Nicholas Piramal India Ltd. Novel antibacterial compounds. WO2007119201A2; 2007
   Google Scholar
• Novobiotic. Novel macrocyclic lactams. US2009/0149395A1; 2009
   Google Scholar
• Microbial Chemistry Research Foundation. New compound amycolamicin, method for producing the same and use of the same. 2009203195A; 2009
   Google Scholar
• University of British Columbia. Novel enedieyne compound and uses thereof. WO2007038868A2; 2007
   Google Scholar
• Davies J, Wang H, Taylor T, Uncialamycin, a new enediyne antibiotic. Org Lett 2005;7:5233-6
   PubMed Web of Science ®Google Scholar
• The University of Queensland and Microbial Screening Technologies PTY Ltd. Polyketide xanthones and uses thereof. WO2207095696A1; 2007
   Google Scholar
• Ratnayake R, Lacey E, Tennant S, Kibdelones: novel anticancer polyketides from a rare Australian Actinomycete. Chem Eur J 2007;13:1610-19
   Google Scholar
• Kitasato University. Novel compound, process for production thereof, and use thereof. WO2009034156A1; 2009
   Google Scholar
• Taro Pharmaceuticals. Novel Streptomyces-derived antimicrobial compound and method of using same against antibiotic-resistant bacteria. WO2007127293A2; 2007
   Google Scholar
• Panstwowy Zaklad Higieny. An inhibitor of DD-peptidase and its use as antibiotic or anticancer drug. WO2009028972A1; 2009
   Google Scholar
• Helmholtz-Zentrum fur Infektionsforschung GmbH. Thuggacin-type macrolide antibiotics and their use as antimycobacterial agents. WO2008068127A1; 2008
   Google Scholar
• Helmholtz-Zentrum fur infektionsforschung GmbH. Elansolids, novel natural metabolites of flxibacter and antibiotically active derivatives. EP2093212A1; 2008
   Google Scholar
• Korea Institute of Science and Technology. The co-culture method of Sphingomonas sp bacterial strain and Aspergillus sp. fungus strain, new anti-cancer and antibiotic glionitrins derived from this co-culture method, and pharmaceutical composition containing glionitrins or pharmaceutically acceptable salt thereof as an active ingredient. WO2009066876A2; 2009
   Google Scholar
• Park HB, Kwon HC, Lee CH, Glionitrin A, an antibiotic-antitumor metabolite derived from competitive interaction between abandoned mine microbes. J Nat Prod 2009;72:248-52
   Google Scholar
• Nimura Genetic Solutions Co., Ltd and Forest Research Institute Malaysia. Novel antibiotics, bispolides A1, A2, and A3 and bispolides B1, B2a, B2b, and B3 and methods for producing the antibiotics. EP2035758A1; 2007
   Google Scholar
• Okujo N, Iinuma H, George A, Bispolides, novel 20-membered ring macrodiolide antibiotics from microbispora. J Antibiot (Tokyo) 2007;60:216-19
   PubMed Web of Science ®Google Scholar
• Marine Biotechnology Institute Co., Ltd. Novel antibiotics. JP2007223969; 2007
   Google Scholar
• Oku N, Kawabata K, Adachi K, Unnarmicins A and C, new antibacterial depsipeptides produced by marine bacterium Photobacterium sp. MBIC06485. J Antibiot (Tokyo) 2008;61:11-17
   PubMed Web of Science ®Google Scholar
• Marine Biotechnology Institute Co., Ltd. Novel antibiotics. JP2007230911; 2007
   Google Scholar
• Meiji Seika Kaisha, Ltd. Novel antibiotic SF2847, method of preparing it and medicinal compositions. JP2007097548; 2007
   Google Scholar
• Julius-Maximilians-Universitaat Wuerzburg and Johannes Gutenberg-universitat Mainz and Stiftung Alfred Wergener Institut fur polar und Meeresforschung. Tajixanthone hydrate and tajixanthone hydrate derivatives, biological activities thereof, and use thereof. WO2005003085; 2005
   Google Scholar